InfuSystem Holdings (INFU) Capital Expenditures Growth (1y) (2011 - 2026)
InfuSystem Holdings (INFU) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -6.52% |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | 80.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 80.37% |
| Mar 31, 2026 | 121.54% |
| Dec 31, 2025 | 426.84% |
| Sep 30, 2025 | 104.77% |
| Jun 30, 2025 | 20.34% |
| Mar 31, 2025 | -93.88% |
| Dec 31, 2024 | 60.29% |
| Sep 30, 2024 | -191.49% |
| Jun 30, 2024 | 405.65% |
| Mar 31, 2024 | -218.61% |
| Dec 31, 2023 | -254.40% |
| Sep 30, 2023 | 227.90% |
| Jun 30, 2023 | 904.55% |
| Mar 31, 2023 | 673.17% |
| Dec 31, 2022 | 51.59% |
| Sep 30, 2022 | 337.93% |
| Jun 30, 2022 | -107.48% |
| Mar 31, 2022 | 2.50% |
| Dec 31, 2021 | 1,119.44% |
| Sep 30, 2021 | 59.01% |